Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cellsStanley Ly, Venkata Lokesh Battula|Journal for ImmunoTherapy of Cancer|2021Cited by 51